As the COVID-19 pandemic sparked long periods of isolation and separation, in life sciences, scientists and researchers have come together like never before. Realizing that collaboration is key to faster breakthroughs, the NIH, FDA, and […]
Cell and gene therapies are at an inflection point, as increasing quantities of clinical data highlight both their potential and their challenges before they can become mainstream therapies treating genetic diseases. Chief among them, according […]
The Serum Institute of India (SII), which bagged the go-ahead last month to start Covovax trials on children above seven years old, could export 30 million COVID-19 vaccine doses to WHO-backed COVAX by December. The […]
COVID sufferers in the UK are now able to access a course of tablets from their GP to avoid the need for hospitalisation. AiPharma’s antiviral treatment, favipiravir, is currently taken orally over a course of […]
NICE has published draft guidance for public consultation which does not recommed tucatinib, in combination with trastuzumab and capecitabine, for some types of breast cancer. Tucatinib is licenced for treating HER2-positive (human epidermal growth factor […]